In schools of business, even, people do work and consult with pharmaceutical companies. They have connections and have experience, but they do not have the direct and very significant conflicts that are brought to the table when it's a representative of one particular industry and not the pharmaceutical industry as a whole.
On December 7th, 2009. See this statement in context.